Rhythm Pharma (RYTM) Surges as FDA Extends Review for IMCIVREE
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) is a biopharmaceutical company founded with a singular scientific focus: developing transformative therapies for…
Browsing Tag